Chantal Mahon
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Neuroscience and Neuropharmacology Research, Advanced MRI Techniques and Applications, Receptor Mechanisms and Signaling, Pharmacological Effects and Toxicity Studies, Pharmaceutical studies and practices
Most-Cited Works
- → Equivalent Dynamic Human Brain NK1-Receptor Occupancy Following Single-Dose i.v. Fosaprepitant vs. Oral Aprepitant as Assessed by PET Imaging(2012)43 cited
- → Preclinical to Human Translational Pharmacology of the Novel M1 Positive Allosteric Modulator MK-7622(2018)38 cited
- → Odanacatib, a Selective Cathepsin K Inhibitor, Demonstrates Comparable Pharmacodynamics and Pharmacokinetics in Older Men and Postmenopausal Women(2013)32 cited
- → Prednisone has no effect on the pharmacokinetics of CYP3A4 metabolized drugs – midazolam and odanacatib(2014)22 cited
- → Single‐dose euglycaemic clamp studies demonstrating pharmacokinetic and pharmacodynamic similarity between MK ‐1293 insulin glargine and originator insulin glargine ( L antus) in subjects with type 1 diabetes and healthy subjects(2017)20 cited
- → Early-stage comparative effectiveness: Randomized controlled trial with histamine inverse agonist MK-7288 in excessive daytime sleepiness patients(2013)14 cited
- The pharmacokinetics and tolerability of telcagepant, a novel calcitonin gene related peptide (CGRP) receptor antagonist, in healthy subjects and migraineurs(2009)
- THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF TELCAGEPANT, A NOVEL CALCITONIN GENE RELATED PEPTIDE (CGRP) RECEPTOR ANTAGONIST, IN HEALTHY SUBJECTS AND MIGRAINEURS(2009)
- → Reproducibility of the Determination of 13C‐Labeling of Glutamate and Glutamine in the Human Brain Using selPOCE‐MRS at 7 T Upon [U‐13C]–Labeled Glucose Infusion(2025)1 cited
- → Issue Information(2019)1 cited